Notice of Results

RNS Number : 6788W

Venn Life Sciences Holdings PLC

21 August 2015

 

Venn Life Sciences Holdings Plc

("Venn" the "Company" or the "Group")

Notice of Results

Investor Results Presentation

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be reporting its interim results for the six months ended 30 June 2015 on Tuesday 22 September 2015.

Analyst presentation

Tony Richardson, Chief Executive Officer and Jonathan Hartshorn, Chief Financial Officer will be hosting an analyst briefing on the day of results, Tuesday 22 September 2015, at 9.30am at Walbrook PR, 4 Lombard Street, London, EC3V 9HD.

Investor results presentation

A briefing for all investors will take place on Tuesday 22 September 2015 at Rocket, 6 Adams Court, Old Broad Street, London, EC4N 1DX from 5.00pm for a 5.15pm start, and will be followed by drinks and canapés.

If you would like to register to attend either presentation, or require further information, please contact Lianne Cawthorne on [phone] or email [e-mail] 

For further information:

Enquiries:

Venn Life Sciences Holdings Plc	www.vennlifesciences.com
Tony Richardson, Chief Executive Officer Jonathan Hartshorn, Chief Financial Officer	Tel: [phone]                Tel: [phone]
Orla McGuinness, Marketing Manager	Tel: [phone]
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones (Corporate Finance)	Tel: [phone]
Alex Davies (Institutional Sales)	Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn also has an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

 

END

 

 

NORQBLFLEVFBBBB